MAG
HAE icon

Millrace Asset Group’s Haemonetics HAE Stock Holding History

Millrace Asset Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,998
Closed -$1.11M – 75
2023
Q4 		$1.11M Sell
12,998
-6,266
-33% -$542K 1.1% 52
2023
Q3 		$1.73M Sell
19,264
-1,442
-7% -$129K 2.13% 20
2023
Q2 		$1.76M Buy
+20,706
New +$1.75M 1.85% 30
2020
Q2 		– Sell
-9,872
Closed -$984K – 81
2020
Q1 		$984K Sell
9,872
-4,793
-33% -$520K 1.49% 36
2019
Q4 		$1.69M Buy
14,665
+3,265
+29% +$395K 1.83% 18
2019
Q3 		$1.44M Buy
11,400
+2,400
+27% +$305K 1.69% 28
2019
Q2 		$1.08M Buy
+9,000
New +$885K 1.12% 52

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millrace Asset Group's HAE Position: Q1 2024 in Review

Millrace Asset Group sold out of Haemonetics (HAE) in Q1 2024, closing a stake of 12,998 shares — an estimated $1.11M sold.

Millrace Asset Group first reported a position in HAE in Q2 2019 and held it in 7 quarters. The position peaked at $1.76M in Q2 2023. 298 funds tracked by Wall St. Rank hold HAE as of Q1 2024.

  • Millrace Asset Group reported no remaining Haemonetics position as of Q1 2024 after selling out during the quarter.
  • Millrace Asset Group sold 12,998 Haemonetics shares in Q1 2024, an estimated $1.11M.
  • Millrace Asset Group first reported a position in Haemonetics in Q2 2019 and held it in 7 quarters.
  • Millrace Asset Group's Haemonetics position peaked at $1.76M in Q2 2023.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q1 2024.

Based on Millrace Asset Group's 13F filing for Q1 2024, filed 13 May 2024.